Insider Transactions in Q3 2025 at Entrada Therapeutics, Inc. (TRDA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 02
2025
|
Kory James Wentworth Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,734
-1.44%
|
$8,670
$5.43 P/Share
|
|
Sep 02
2025
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,760
-0.88%
|
$8,800
$5.43 P/Share
|
|
Sep 02
2025
|
Nathan J Dowden President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,746
-0.97%
|
$8,730
$5.43 P/Share
|
|
Sep 02
2025
|
Dipal Doshi CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,723
-2.06%
|
$43,615
$5.43 P/Share
|
|
Jul 09
2025
|
5 Am Ventures V, L.P. |
SELL
Open market or private sale
|
Indirect |
6,935
-0.63%
|
$48,545
$7.5 P/Share
|
|
Jul 09
2025
|
5 Am Ventures V, L.P. |
SELL
Open market or private sale
|
Direct |
20,065
-0.63%
|
$140,455
$7.5 P/Share
|
|
Jul 09
2025
|
Kush Parmar |
SELL
Open market or private sale
|
Indirect |
27,000
-0.63%
|
$189,000
$7.5 P/Share
|
|
Jul 01
2025
|
5 Am Ventures V, L.P. |
SELL
Open market or private sale
|
Indirect |
6,422
-0.58%
|
$44,954
$7.12 P/Share
|
|
Jul 01
2025
|
5 Am Ventures V, L.P. |
SELL
Open market or private sale
|
Direct |
18,578
-0.58%
|
$130,046
$7.12 P/Share
|
|
Jul 01
2025
|
Kush Parmar |
SELL
Open market or private sale
|
Indirect |
25,000
-0.58%
|
$175,000
$7.12 P/Share
|